case_images: PMC8761613_01
case_images: The chest CT images of patient 1. (A) The chest CT before CHOPE (bilateral axillary, mediastinum, bilateral hilar, and bilateral cervical lymphonodus were enlarged); (B) the chest CT after three cycles of CHOPE, before CAOLD (mediastinal and hilar lymphonodus enlarged again; the size of axillary lymphonodus was the same as before); (C) the chest CT after two cycles of CAOLD (mediastinal and hilar lymphonodus were significantly reduced); (D) the chest CT after five cycles of CAOLD (mediastinal and hilar enlarged lymphonodus almost disappeared).
case_images: fonc-11-758445-g001.jpg
case_images: PMC8761613_01_fonc-11-758445-g001.jpg
case_images: f1
case_images: The patient refused to get examined by PET-CT and CR was achieved after two cycles of CAOLD by CT ( Figure 1 ).
case_images: PMC8761613_02
case_images: The PET-CT images of patient 2. (A) PET-CT before chemotherapy (systemic multiple lymphadenopathy with FDG hypermetabolism); (B) PET-CT after three cycles of GEMOX, before CAOLD (multiple enlarged lymphonodus, abnormally high-glucose metabolism, some new lesions, such as left anterior ear, right parotid gland, bilateral oropharynx, and parapharyngeal); (C) PET-CT after four cycles of CAOLD (the enlarged lymphonodus and glucose metabolism disappeared).
case_images: fonc-11-758445-g002.jpg
case_images: PMC8761613_02_fonc-11-758445-g002.jpg
case_images: f2
case_images: Specifically, he achieved CR after four cycles of chemotherapy, which was evaluated by PET-CT ( Figure 2 ).